Correction: Mixed-Methods to Define Meaningful Change using Exit Interview and Clinical Trial Data in Patients with Tenosynovial Giant Cell Tumor (TGCT)

Quality of Life Research, vol. 35

Authors 12

1. Heather L. Gelhorn corresponding
   Affiliation as printed

   Patient-Centered Research, Evidera, Wilmington, NC, USA. heather.gelhorn@thermofisher.com

2. Katelyn N. Cutts
   Affiliation as printed

   Patient-Centered Research, Evidera, Wilmington, NC, USA

3. Brooke Harrow

   Deciphera Pharmaceuticals (United States)

   Affiliation as printed

   Deciphera Pharmaceuticals, LLC, Waltham, MA, USA

4. Christopher Tait

   Deciphera Pharmaceuticals (United States)

   Affiliation as printed

   Deciphera Pharmaceuticals, LLC, Waltham, MA, USA

5. Amanda Saunders

   Deciphera Pharmaceuticals (United States)

   Affiliation as printed

   Deciphera Pharmaceuticals, LLC, Waltham, MA, USA

6. Tsion Fikre
   Affiliation as printed

   Patient-Centered Research, Evidera, Wilmington, NC, USA

7. Yipin Han
   Affiliation as printed

   Patient-Centered Research, Evidera, Wilmington, NC, USA

8. Nicholas A. Zeringo

   Deciphera Pharmaceuticals (United States)

   Affiliation as printed

   Deciphera Pharmaceuticals, LLC, Waltham, MA, USA

9. Michiel Van De Sande Aachen Department of Orthopedic Surgery

   Leiden University Medical Center

   Affiliation as printed

   Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, Netherlands

10. William Tap

    Memorial Sloan Kettering Cancer Center

    Affiliation as printed

    Memorial Sloan Kettering Cancer Center, New York, NY, USA

11. Hans Gelderblom Aachen Department of Orthopedic Surgery

    Leiden University Medical Center

    Affiliation as printed

    Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, Netherlands

12. Nicholas Bernthal

    University of California, Los Angeles

    Affiliation as printed

    Department of Orthopedic Surgery, University of California Los Angeles, Los Angeles, CA, USA